Active substance (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Technical information
Presentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
Q970fU4tcXgCqHLH
Listen
